Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06645769
EARLY_PHASE1
Na-Phenylbutyrate VAscular Trial
Sponsor: University of Pennsylvania
View on ClinicalTrials.gov
Summary
This study will investigate if the drug sodium phenylbutyrate (NaPB) impacts blood pressure and vascular function in healthy volunteers and in patients with diabetes.
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-06-01
Completion Date
2029-06-01
Last Updated
2026-03-12
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Sodium Phenylbutyrate
will be compared to placebo
OTHER
Placebo
will be compared to NaPB